Anne-Marie Cleton-Jansen
Department of Pathology
Leiden University Medical Center
Albinusdreef 2
Leiden
Netherlands
Name/email consistency: high
- Mesenchymal stem cell transformation and sarcoma genesis. Xiao, W., Mohseny, A.B., Hogendoorn, P.C., Cleton-Jansen, A.M. Clin. Sarcoma. Res (2013)
- Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways. Cleton-Jansen, A.M., Anninga, J.K., Briaire-de Bruijn, I.H., Romeo, S., Oosting, J., Egeler, R.M., Gelderblom, H., Taminiau, A.H., Hogendoorn, P.C. Br. J. Cancer (2009)
- ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism. Cleton-Jansen, A.M., van Eijk, R., Lombaerts, M., Schmidt, M.K., Van't Veer, L.J., Philippo, K., Zimmerman, R.M., Peterse, J.L., Smit, V.T., van Wezel, T., Cornelisse, C.J. BMC. Cancer (2008)
- Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma. Cleton-Jansen, A.M., van Beerendonk, H.M., Baelde, H.J., Bovée, J.V., Karperien, M., Hogendoorn, P.C. Clin. Cancer Res. (2005)
- A distinct phenotype characterizes tumors from a putative genetic trait involving chondrosarcoma and breast cancer occurring in the same patient. Cleton-Jansen, A.M., Timmerman, M.C., van de Vijver, M.J., van Asperen, C.J., Kroon, H.M., Eilers, P.H., Hogendoorn, P.C. Lab. Invest. (2004)
- Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer. Cleton-Jansen, A.M., Buerger, H., Haar, N., Philippo, K., van de Vijver, M.J., Boecker, W., Smit, V.T., Cornelisse, C.J. Genes. Chromosomes. Cancer (2004)
- E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?. Cleton-Jansen, A.M. Breast Cancer Res. (2002)
- Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cleton-Jansen, A.M., Callen, D.F., Seshadri, R., Goldup, S., Mccallum, B., Crawford, J., Powell, J.A., Settasatian, C., van Beerendonk, H., Moerland, E.W., Smit, V.T., Harris, W.H., Millis, R., Morgan, N.V., Barnes, D., Mathew, C.G., Cornelisse, C.J. Cancer Res. (2001)
